[English] 日本語
Yorodumi- EMDB-52254: Influenza Neuraminidase in complex with N-Acyl Oseltamivir inhibitor -
+
Open data
-
Basic information
| Entry | ![]() | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Title | Influenza Neuraminidase in complex with N-Acyl Oseltamivir inhibitor | |||||||||
Map data | ||||||||||
Sample |
| |||||||||
Keywords | Influenza / Neuraminidase / VIRAL PROTEIN | |||||||||
| Function / homology | Function and homology informationexo-alpha-sialidase / exo-alpha-sialidase activity / viral budding from plasma membrane / carbohydrate metabolic process / host cell plasma membrane / virion membrane / membrane / metal ion binding Similarity search - Function | |||||||||
| Biological species | ![]() Influenza A virus | |||||||||
| Method | single particle reconstruction / cryo EM / Resolution: 2.25 Å | |||||||||
Authors | Moran E / Davies G | |||||||||
| Funding support | European Union, 1 items
| |||||||||
Citation | Journal: Proc Natl Acad Sci U S A / Year: 2026Title: Oseltamivir aziridines are potent influenza neuraminidase inhibitors and imaging agents. Authors: Merijn B L Vriends / Elisha Moran / Martín Calvelo / Thomas Hansen / Isabelle B Pickles / Xincheng Xin / Marieke Biezeno / Zachary W B Armstrong / Maria J Ferraz / Lei Li / Alice Lilley / ...Authors: Merijn B L Vriends / Elisha Moran / Martín Calvelo / Thomas Hansen / Isabelle B Pickles / Xincheng Xin / Marieke Biezeno / Zachary W B Armstrong / Maria J Ferraz / Lei Li / Alice Lilley / Ruth Harvey / Dmitri V Filippov / Qinghua Liao / Sybrin P Schröder / Gijsbert A van der Marel / Marta Artola / Johannes M F G Aerts / James N Blaza / Jeroen D C Codée / Carme Rovira / Herman S Overkleeft / Gideon J Davies / ![]() Abstract: Influenza neuraminidase (NA) is a critical target for seasonal and pandemic antivirals, including the strains of current concern. Current treatments, such as Zanamivir and Oseltamivir, are limited by ...Influenza neuraminidase (NA) is a critical target for seasonal and pandemic antivirals, including the strains of current concern. Current treatments, such as Zanamivir and Oseltamivir, are limited by noncovalent binding and emerging resistance. We hypothesized that Oseltamivir aziridines would unite transition-state mimicry for tight binding, with aziridine-enabled covalent capture of the catalytic tyrosine, thereby supporting both therapy and activity-based quantification. Here, we present oseltamivir-based aziridines, inspired by cyclophellitol chemistry, that act as covalent inhibitors and activity-based probes via an -acylaziridine warhead. Free-energy calculations, and NMR observations, indicate a H half-chair preference consistent with the NA transition state, and selected analogues inhibit multiple NA subtypes with low nanomolar binding constants. Diverse evidence establishes covalency: time-dependent inactivation, inhibitor washout, intact-mass shifts, MS/MS identification of a tyrosine adduct, and QM/MM reaction profiles, while cryoEM of N1 aligns with the proposed binding mode, revealing an elimination product. The inhibitors demonstrate formidable activity against diverse viral neuraminidases, including H5N1, and further enable imaging and quantification of active NA. With their dual therapeutic and diagnostic potential, these first-in-class inhibitors indeed benefit from transition state mimicry and covalency, and thus offer a powerful platform for antiviral development and neuraminidase imaging, addressing urgent global health needs in influenza treatment and prevention. | |||||||||
| History |
|
-
Structure visualization
| Supplemental images |
|---|
-
Downloads & links
-EMDB archive
| Map data | emd_52254.map.gz | 28.5 MB | EMDB map data format | |
|---|---|---|---|---|
| Header (meta data) | emd-52254-v30.xml emd-52254.xml | 23.6 KB 23.6 KB | Display Display | EMDB header |
| FSC (resolution estimation) | emd_52254_fsc.xml | 9.1 KB | Display | FSC data file |
| Images | emd_52254.png | 76.6 KB | ||
| Masks | emd_52254_msk_1.map | 30.5 MB | Mask map | |
| Filedesc metadata | emd-52254.cif.gz | 7 KB | ||
| Others | emd_52254_half_map_1.map.gz emd_52254_half_map_2.map.gz | 20.4 MB 20.4 MB | ||
| Archive directory | http://ftp.pdbj.org/pub/emdb/structures/EMD-52254 ftp://ftp.pdbj.org/pub/emdb/structures/EMD-52254 | HTTPS FTP |
-Related structure data
| Related structure data | ![]() 9hlhMC ![]() 9hlgC ![]() 9hliC M: atomic model generated by this map C: citing same article ( |
|---|---|
| Similar structure data | Similarity search - Function & homology F&H Search |
-
Links
| EMDB pages | EMDB (EBI/PDBe) / EMDataResource |
|---|---|
| Related items in Molecule of the Month |
-
Map
| File | Download / File: emd_52254.map.gz / Format: CCP4 / Size: 30.5 MB / Type: IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Projections & slices | Image control
Images are generated by Spider. | ||||||||||||||||||||||||||||||||||||
| Voxel size | X=Y=Z: 0.9 Å | ||||||||||||||||||||||||||||||||||||
| Density |
| ||||||||||||||||||||||||||||||||||||
| Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||
| Details | EMDB XML:
|
-Supplemental data
-Mask #1
| File | emd_52254_msk_1.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-Half map: #2
| File | emd_52254_half_map_1.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-Half map: #1
| File | emd_52254_half_map_2.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-
Sample components
-Entire : Influenza Neuraminidase in complex with N-Acyl Oseltamivir inhibitor
| Entire | Name: Influenza Neuraminidase in complex with N-Acyl Oseltamivir inhibitor |
|---|---|
| Components |
|
-Supramolecule #1: Influenza Neuraminidase in complex with N-Acyl Oseltamivir inhibitor
| Supramolecule | Name: Influenza Neuraminidase in complex with N-Acyl Oseltamivir inhibitor type: complex / ID: 1 / Parent: 0 / Macromolecule list: #1 |
|---|---|
| Source (natural) | Organism: ![]() Influenza A virus |
-Macromolecule #1: Neuraminidase
| Macromolecule | Name: Neuraminidase / type: protein_or_peptide / ID: 1 / Number of copies: 4 / Enantiomer: LEVO / EC number: exo-alpha-sialidase |
|---|---|
| Source (natural) | Organism: ![]() Influenza A virus |
| Molecular weight | Theoretical: 42.499523 KDa |
| Recombinant expression | Organism: Trichoplusia ni (cabbage looper) |
| Sequence | String: VKLAGNSSLC PVSGWAPLSK DNSVRIGSKG DVFVIREPFI SCSPLECRTF FLTQGALLND KHSNGTIKDR SPYRTLMSVP IGSVPSPYN ARFESIAWSA SACHDGINWL TIGITGPDNG AVAILKYNGI ITDTIKSWRN NILRTQESEC ACVNGSCFTV M TDGPSNGQ ...String: VKLAGNSSLC PVSGWAPLSK DNSVRIGSKG DVFVIREPFI SCSPLECRTF FLTQGALLND KHSNGTIKDR SPYRTLMSVP IGSVPSPYN ARFESIAWSA SACHDGINWL TIGITGPDNG AVAILKYNGI ITDTIKSWRN NILRTQESEC ACVNGSCFTV M TDGPSNGQ ASYKIFRIEK GKIVKSVEMN APNYHYEECS CYPDSSEITC VCRDNWHGSN RPWVSFNQNL EYQIGYICSG IF GDNPRPN DKTGSCGPVS SNGANGVKGF SFKYGNGVWI GRTKSISSRN GFEMIWDPNG WTGTDNNFSI KQDIVGINEW SGY SGSFVM HPELTGLDCI VPCFWVELIR GRPKENTIWT SGSSISFCGV NSDTVGWSWP DGAELPFTID K UniProtKB: Neuraminidase |
-Macromolecule #2: (3~{S},4~{R},5~{R},6~{R})-4-acetamido-3-azanyl-5-pentan-3-yloxy-6...
| Macromolecule | Name: (3~{S},4~{R},5~{R},6~{R})-4-acetamido-3-azanyl-5-pentan-3-yloxy-6-(pent-4-ynoylamino)cyclohexene-1-carboxylic acid type: ligand / ID: 2 / Number of copies: 4 / Formula: A1IVW |
|---|---|
| Molecular weight | Theoretical: 379.451 Da |
-Macromolecule #3: 2-acetamido-2-deoxy-beta-D-glucopyranose
| Macromolecule | Name: 2-acetamido-2-deoxy-beta-D-glucopyranose / type: ligand / ID: 3 / Number of copies: 4 / Formula: NAG |
|---|---|
| Molecular weight | Theoretical: 221.208 Da |
| Chemical component information | ![]() ChemComp-NAG: |
-Macromolecule #4: CALCIUM ION
| Macromolecule | Name: CALCIUM ION / type: ligand / ID: 4 / Number of copies: 4 / Formula: CA |
|---|---|
| Molecular weight | Theoretical: 40.078 Da |
-Macromolecule #5: water
| Macromolecule | Name: water / type: ligand / ID: 5 / Number of copies: 392 / Formula: HOH |
|---|---|
| Molecular weight | Theoretical: 18.015 Da |
| Chemical component information | ![]() ChemComp-HOH: |
-Experimental details
-Structure determination
| Method | cryo EM |
|---|---|
Processing | single particle reconstruction |
| Aggregation state | particle |
-
Sample preparation
| Concentration | 1.5 mg/mL | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buffer | pH: 7 Component:
Details: 25 mM Tris pH 7.0 150 mM NaCl, 100 mM CaCl2 | ||||||||||||
| Grid | Model: UltrAuFoil R1.2/1.3 / Material: GOLD / Mesh: 200 / Pretreatment - Type: GLOW DISCHARGE / Pretreatment - Time: 180 sec. / Pretreatment - Atmosphere: OTHER | ||||||||||||
| Vitrification | Cryogen name: ETHANE / Chamber humidity: 100 % / Chamber temperature: 277.15 K / Instrument: FEI VITROBOT MARK IV / Details: Blot force -10 and blot time 3 seconds. |
-
Electron microscopy
| Microscope | TFS KRIOS |
|---|---|
| Image recording | Film or detector model: GATAN K3 (6k x 4k) / Average electron dose: 43.99 e/Å2 |
| Electron beam | Acceleration voltage: 300 kV / Electron source: FIELD EMISSION GUN |
| Electron optics | Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD / Nominal defocus max: 1.4000000000000001 µm / Nominal defocus min: 0.6 µm |
| Sample stage | Cooling holder cryogen: NITROGEN |
| Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |
Movie
Controller
About Yorodumi



Keywords
Influenza A virus
Authors
Citation








Z (Sec.)
Y (Row.)
X (Col.)












































Trichoplusia ni (cabbage looper)

Processing
FIELD EMISSION GUN

